Purdue Pharma exit plan gains steam with OK from Colorado, 14 other states

“Today, we are holding Purdue and the Sacklers accountable for their reprehensible conduct,” Colorado AG says

Share this:

FILE – In this Oct. 21, 2020, file photo, Purdue Pharma headquarters stands in Stamford, Conn. In an agreement disclosed late Wednesday, July 7, 2021, in a filing in U.S. Bankruptcy Court in White Plains, N.Y., more than a dozen states have dropped their objections to OxyContin maker Purdue Pharma’s reorganization plan, edging the company closer to resolving its bankruptcy case. (AP Photo/Mark Lennihan, File)
By Geoff Mulvihill and Shelly Bradbury | sbradbury@denverpost.com | The Associated Press
PUBLISHED: July 8, 2021 at 9:20 a.m. | UPDATED: July 8, 2021 at 11:08 a.m.

Sign up for Newsletters and Alerts

Subscribe
Follow Us
Most Popular

Shelly Bradbury | Courts Reporter

Shelly Bradbury is the courts reporter at the Denver Post. She joined the paper in 2019 and previously worked as a crime reporter at the Pittsburgh Post-Gazette in Pennsylvania and the Chattanooga Times Free Press in Tennessee. She’s been a reporter since 2012, focused on criminal justice. In Pittsburgh, she helped the newspaper earn the 2019 Pulitzer Prize for breaking news after a mass shooting at a local synagogue, and in 2020 she was named a finalist for the Pulitzer Prize in local reporting for an investigation into child sexual abuse among Amish and Mennonite communities.